Tools

LEADER 05291cam 2200577 a 4500

001 1679328;

005 20170427123058.0;

008 121115s2013 nyua b 101 0 eng d;

010 a| 2012945942;

020 a| 9781461441175;

020 a| 146144117X;

035 a| (Sirsi) a4622164;

035 9| 101679328;

041 09 a| eng;

042 a| nlmcopyc;

044 9| United States;

050 14 a| RM301.63b| .C66 2013;

050 4 a| RM301.63b| .I58 2011;

060 00 a| W1b| AD559 v.735 2013;

060 10 a| QW 920;

082 04 a| 619.08b| A243 V.735;

111 2 a| International Complement Therapeutics Conferencen| (5th :d| 2011 :c| Rhodes, Greece)=| ^A1323796;

245 10 a| Complement therapeutics /c| John D. Lambris, V. Michael Holers, Daniel Ricklin, editors.;

260 a| New York :b| Springer Verlag,c| 2013.;

300 a| online resource.;

336 a| textb| txt2| rdacontent;

337 a| unmediatedb| n2| rdamedia;

338 a| volumeb| nc2| rdacarrier;

490 1 a| Advances in experimental medicine and biology,x| 0065-2598 ;v| v. 735;

500 a| " ... Fifth International Complement Therapeutics Conference (June 22-27, 2011) in Rhodes, Greece ... This volume represents a collection of highlights from this conference ..."--Page v.;

504 a| Includes bibliographical references and index.;

505 00 t| Progress and trends in complement therapeutics /r| Daniel Ricklin and John D. Lambris --t| Inhibition of the serine proteases of the complement system /r| P?eter G?al [and others] --t| The role of MASP-1/3 in complement activation /r| Hideharu Sekine [and others] --t| Membrane-bound complement regulatory proteins as biomarkers and potential therapeutic targets for SLE /r| Nibhriti Das, Bintili Biswas, and Rohan Khera --t| DAF as a therapeutic target for steroid hormones : implications for host-pathogen interactions /r| Bogdan Nowicki and Stella Nowicki --t| Targeting gC1qR domains for therapy against infection and inflammation /r| Berhane Ghebrehiwet [and others] --t| The alternative C5a receptor function /r| Hiroshi Nishiura --t| The effects of selective complement and CD14 inhibition on the E. coli-induced tissue factor mRNA upreglation, monocyte tissue factor expression, and tissue factor functional activity in human whole blood /r| O.-L. Brekke [and others] --t| CR2-mediated targeting of complement inhibitors : bench-to-bedside using a novel strategy for site-specific complement modulation /r| V. Michael Holers, B?arbel Rohrer, and Stephen Tomlinson --t| Paroxysmal nocturnal hemoglobinuria and the complement system : recent insights and novel anticomplement strategies /r| Antonio M. Risitano --t| Defective complement action and control defines disease pathology for retinal and renal disorders and provides a basis for new therapeutic approaches /r| Peter F. Zipfel and Nadine Lauer --t| C3 glomerulonephritis/CFHR5 nephropathy is an endemic disease in Cyprus : clinical and molecular findings in 21 families /r| Constantinos Deltas [and others] --t| Complement-targeted therapeutics in periodontitis /r| George Hajishengallis and John D. Lambris --t| Complement system activation in cardiac and skeletal muscle pathology : friend or foe? /r| Maro Syriga and Manolis Mavroidis --t| Innate immunity as orchestrator of bone marrow homing for hematopoietic stem/progenitor cells /r| Mariusz Z. Ratajczak [and others] --t| Complement-mediated microvascular injury leads to chronic rejection /r| Mohammad A. Khan and Mark R. Nicolls --t| Targeting complement at the time of transplantation /r| Steven Sacks [and others] --t| Evaluation of the blood compatibility of materials, cells, and tissues : basic concepts, test models, and practical guidelines /r| Kristina N. Ekdahl [and others] --t| Noninvasive detection of complement activation through radiologic imaging /r| Joshua M. Thurman and B?arbel Rohrer --t| Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics /r| Michael R. Mehan [and others] --t| Complement in action : an analysis of patent trends from 1976 through 2011 /r| Kun Yang [and others].;

538 a| Mode of Access: World Wide Web;

650 12 a| Complement Inactivating Agentsx| pharmacology.=| ^A1326641;

650 22 a| Complement System Proteinsx| drug effects.=| ^A1326878;

650 22 a| Receptors, Complementx| drug effects.=| ^A1327069;

650 22 a| Drug Design.=| ^A925973;

650 22 a| Drug Delivery Systems.=| ^A927384;

655 4 a| Electronic books.;

700 1 a| Lambris, J. D.q| (John D.)=| ^A819190;

700 1 a| Holers, V. Michael,d| 1952-=| ^A819191;

700 1 a| Ricklin, Daniel.=| ^A1324976;

830 0 a| Advances in experimental medicine and biologyv| v. 735.x| 0065-2598=| ^A103;

856 4 z| Connect to this resource onlineu| https://go.openathens.net/redirector/ecu.edu?url=http://www.r2library.com/Resource/Title/146144117X;

949 a| CLICK ON WEB ADDRESS w| ASIS h| HSL10 o| hmb;

949 a| CLICK ON WEB ADDRESS w| ASIS h| JOYNER252 o| hmb;

596 a| 1 4;

998 a| 4622164;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 4622164-1001l| HSLELECm| HSLr| Ys| Yt| HR2DDAUu| 1/30/2017x| EBOOKz| HERESOURCEo| .STAFF. hmb;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 4622164-2001l| JNETm| JOYNERr| Ys| Yt| JNER2DDAUu| 1/30/2017x| EBOOKz| JERESOURCEo| .STAFF. hmb;

Complement therapeutics / John D. Lambris, V. Michael Holers, Daniel Ricklin, editors.

Author/creator	International Complement Therapeutics Conference
Other author	Lambris, J. D. (John D.)
Other author	Holers, V. Michael, 1952-
Other author	Ricklin, Daniel.
Format	Book
Publication Info	New York : Springer Verlag, 2013.
Description	online resource.
Supplemental Content	Connect to this resource online
Subjects	Complement Inactivating Agents--pharmacology. Complement System Proteins--drug effects. Receptors, Complement--drug effects. Drug Design. Drug Delivery Systems.

Series	Advances in experimental medicine and biology, 0065-2598 ; v. 735 Advances in experimental medicine and biology v. 735. 0065-2598 ^A103
Contents	Progress and trends in complement therapeutics / Daniel Ricklin and John D. Lambris -- Inhibition of the serine proteases of the complement system / P?eter G?al [and others] -- The role of MASP-1/3 in complement activation / Hideharu Sekine [and others] -- Membrane-bound complement regulatory proteins as biomarkers and potential therapeutic targets for SLE / Nibhriti Das, Bintili Biswas, and Rohan Khera -- DAF as a therapeutic target for steroid hormones : implications for host-pathogen interactions / Bogdan Nowicki and Stella Nowicki -- Targeting gC1qR domains for therapy against infection and inflammation / Berhane Ghebrehiwet [and others] -- The alternative C5a receptor function / Hiroshi Nishiura -- The effects of selective complement and CD14 inhibition on the E. coli-induced tissue factor mRNA upreglation, monocyte tissue factor expression, and tissue factor functional activity in human whole blood / O.-L. Brekke [and others] -- CR2-mediated targeting of complement inhibitors : bench-to-bedside using a novel strategy for site-specific complement modulation / V. Michael Holers, B?arbel Rohrer, and Stephen Tomlinson -- Paroxysmal nocturnal hemoglobinuria and the complement system : recent insights and novel anticomplement strategies / Antonio M. Risitano -- Defective complement action and control defines disease pathology for retinal and renal disorders and provides a basis for new therapeutic approaches / Peter F. Zipfel and Nadine Lauer -- C3 glomerulonephritis/CFHR5 nephropathy is an endemic disease in Cyprus : clinical and molecular findings in 21 families / Constantinos Deltas [and others] -- Complement-targeted therapeutics in periodontitis / George Hajishengallis and John D. Lambris -- Complement system activation in cardiac and skeletal muscle pathology : friend or foe? / Maro Syriga and Manolis Mavroidis -- Innate immunity as orchestrator of bone marrow homing for hematopoietic stem/progenitor cells / Mariusz Z. Ratajczak [and others] -- Complement-mediated microvascular injury leads to chronic rejection / Mohammad A. Khan and Mark R. Nicolls -- Targeting complement at the time of transplantation / Steven Sacks [and others] -- Evaluation of the blood compatibility of materials, cells, and tissues : basic concepts, test models, and practical guidelines / Kristina N. Ekdahl [and others] -- Noninvasive detection of complement activation through radiologic imaging / Joshua M. Thurman and B?arbel Rohrer -- Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics / Michael R. Mehan [and others] -- Complement in action : an analysis of patent trends from 1976 through 2011 / Kun Yang [and others].
General note	" ... Fifth International Complement Therapeutics Conference (June 22-27, 2011) in Rhodes, Greece ... This volume represents a collection of highlights from this conference ..."--Page v.
Bibliography note	Includes bibliographical references and index.
Technical details	Mode of Access: World Wide Web
Genre/form	Electronic books.
LCCN	2012945942
ISBN	9781461441175
ISBN	146144117X

Complement therapeutics / John D. Lambris, V. Michael Holers, Daniel Ricklin, editors.

Click here for more information about this title